Integer Holdings Corporation Announces Launch of Convertible Notes Offering

Core Viewpoint - Integer Holdings Corporation plans to offer $750 million in convertible senior notes due 2030, with an option for initial purchasers to buy an additional$125 million [1][2]. Group 1: Offering Details - The convertible notes will be senior unsecured obligations, maturing on March 15, 2030, and will accrue interest payable semi-annually [5]. - The company intends to use part of the net proceeds to pay for capped call transactions and to exchange existing convertible senior notes due 2028 [3][4]. - The notes will be convertible under specific conditions before December 15, 2029, and at any time thereafter until two trading days before maturity [5]. Group 2: Capped Call Transactions - Capped call transactions are expected to reduce potential dilution of the company's common stock upon conversion of the notes [7]. - The company anticipates that option counterparties will engage in stock transactions that could influence the market price of the company's common stock [8][9]. Group 3: Note Exchange Transactions - The company plans to enter into note exchange transactions with holders of existing convertible notes, which may lead to significant market activity affecting the stock price [10][11]. - The company will terminate existing capped call transactions corresponding to the amount of existing notes exchanged, which may also impact the market price of the common stock [11]. Group 4: Company Overview - Integer Holdings Corporation is a leading medical device contract development and manufacturing organization, serving various markets including cardiac rhythm management and neuromodulation [14].